Nova Mentis Life Science Corp. and Mycrodose Therapeutics, a US pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announce the successful milestone of merging NOVA’s psilocybin-based drug development program with Mycrodose’s transdermal technology.
Compound Psilocybin
Visit article
Category Press Release
Country Canada
Companies Featured
Nova MentisNova Mentis is a Canadian listed (CSE, FSE) company that holds two subsidiaries, Nova Mentis Biotech and Pilz BioSciences that investigate psychedelics as medicines for a variety of mental health indicators.